CG Oncology (CGON) Depreciation and Depletion (2024 - 2026)
CG Oncology (CGON) posted Depreciation and Depletion of $800000.0 for Q1 2026, little changed on a QoQ basis from $800000.0 in Q4 2025, and up 700.0% year-over-year from $100000.0 in Q1 2025.
CG Oncology (CGON) Depreciation and Depletion (2024 - 2026) Analysis & Trends
CG Oncology's Depreciation and Depletion history runs 3 years deep, the most recent figure standing at $800000.0 for Q1 2026.
- Quarterly Depreciation and Depletion rose 700.0% year-over-year to $800000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (changed N/A YoY) and the FY2025 annual result came in at $1.4 million, up 1300.0% from the prior year.
- Depreciation and Depletion was $800000.0 for Q1 2026 at CG Oncology, roughly flat from $800000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $800000.0 in Q4 2025 and bottomed at $100000.0 in Q3 2024.
- A 3-year average of $460000.0 and a median of $500000.0 in 2025 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2025 — Depreciation and Depletion soared 400.0% — and 2026, when it jumped 700.0%.
- CG Oncology's Depreciation and Depletion stood at $100000.0 in 2024, then soared by 700.0% to $800000.0 in 2025, then changed by 0.0% to $800000.0 in 2026.
- Business Quant data shows CGON's Depreciation and Depletion at $800000.0 in Q1 2026, $800000.0 in Q4 2025, and $500000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | CG Oncology | 6.01 Bn | 6.01 Bn | -1.88 Mn | 800,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 800,000.00 |
| Mar 31, 2026 | 800,000.00 |
| Dec 31, 2025 | 800,000.00 |
| Dec 31, 2025 | 800,000.00 |
| Sep 30, 2025 | 500,000.00 |
| Sep 30, 2025 | 500,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |